Nephroapp
Exam Cases MCQ Bank

Search

Find tools, topics, and resources

Welcome to Nephroapp
Sign in to keep your progress and bookmarks.
Log in Create account
Explore
Exam cases MCQ Bank Topics Plans and pricing
App
Explore NephroApp
Exam Cases MCQ Bank

Study

Exam cases
MCQ Bank
Fast Recaps
Plans and pricing
‹ Fast Recaps

⭐ Special Topics

5 Fast Recaps

💧 Peritoneal Dialysis ⚡ Electrolytes & Acid–Base 🩸 Hemodialysis & Access 🏥 CRRT / ICU 💓 Hypertension 🫀 Transplant 🔬 Glomerular 🪨 Tubular & Stones 🦴 CKD & Bone-Mineral 🚨 Acute Kidney Injury
Hematuria / proteinuria approach ADPKD / tolvaptan / Mayo classification Drugs raising creatinine without lowering GFR Renal biopsy indications & complications Lupus nephritis — pregnancy planning and proteinuria rise after MMF→azathioprine
19

Hematuria / proteinuria approach

Open the full topic →
Fast Recap · 7 stops

Haematuria and proteinuria at a glance

Confirm true haematuria, localise it (glomerular vs urological), then route it. Watch for rising creatinine, family history and a mass.

  1. Confirmation Dipstick detects haem; microscopy confirms red cells.
  2. filter pipes Localisation Dysmorphic cells and casts: glomerular.
  3. URO NEPHRO WATCH Referral Urology, nephrology or annual monitoring.
  1. 1

    Stop 1 · Confirmation

    Confirmation of haematuria

    Exclude transient causes, confirm on microscopy, screen everyone.

    ≥3 RBC per HPF RA/BAUS: 2 of 3 dips
    1

    Transient causes

    UTI, exercise, menstruation, trauma, instrumentation; repeat once settled.

    2

    Urine microscopy

    ≥3 RBC/HPF; dysmorphic cells or casts.

    3

    Baseline screen

    BP, creatinine/eGFR, urine ACR or PCR.

    UK RA / BAUS

    Asymptomatic non-visible: 2 of 3 dipsticks positive, otherwise stop.

    AUA/SUFU 2025

    One properly collected specimen, ≥3 RBC/HPF.

    History: visible or not, UTI, smoking, cyclophosphamide, family kidney disease, deafness.

    Exam trap

    Dipstick positive, no red cells: haem pigment, myoglobinuria (rhabdomyolysis) or haemoglobinuria (haemolysis).

    Memory hook

    “Dip, then look.” Dipstick flags; microscopy proves.

  2. 2

    Stop 2 · Localisation

    Glomerular vs non-glomerular haematuria

    Subscribers only

Unlock the other 6 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Referral criteria
  2. Nephritic syndrome
  3. Familial thrombotic microangiopathy
  4. Isolated proteinuria
  5. Renal mass evaluation
See the plans →
24

ADPKD / tolvaptan / Mayo classification

Open the full topic →
Fast Recap · 6 stops

ADPKD at a glance

Count cysts by age, measure who grows fast, slow them with tolvaptan, never miss the aneurysm.

  1. Count the cysts Age-based criteria; genetics if unsure.
  2. Measure the volume MRI kidney volume; Mayo class, PROPKD.
  3. Slow the growth Tolvaptan blocks V2 in rapid progressors.
  4. Guard the brain Berry aneurysm: the greatest concern.
  1. 1

    Stop 1 · Diagnosis

    Diagnostic criteria

    Family history decides which cyst count applies.

    15–39 · ≥3 40–59 · ≥2+2 ≥60 · ≥4+4
    Family history positive

    Pei-Ravine unified criteria

    • 15–39 y: ≥3 cysts, either kidney
    • 40–59 y: ≥2 in each kidney
    • ≥60 y: ≥4 in each kidney

    Ultrasound unreliable before age 20.

    Family history negative

    Bilateral cyst count

    ≥10 bilateral cysts: strongly suggests ADPKD.

    Four each side: below threshold, send genetic testing.

    Donor exclusion: age ≥40, <2 cysts excludes (Pei 2009); under 40, use MRI or genetics.
    Mimics: VHL, HNF1B, ARPKD, medullary sponge, acquired cystic disease, lithium. PKD1 worse than PKD2 (ESKD ~58 vs 79 y).

    Exam trap

    Cyst count alone misleads: think tuberous sclerosis, IFT140, ALG8, DNAJB11.

  2. 2

    Stop 2 · Prognosis

    Risk stratification

    Subscribers only

Unlock the other 5 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Tolvaptan therapy
  2. Blood pressure and supportive care
  3. Cyst haemorrhage, infection and stones
  4. Intracranial aneurysm screening
See the plans →
30

Drugs raising creatinine without lowering GFR

Open the full topic →
Fast Recap · 6 stops

Creatinine-raising drugs at a glance

Creatinine up, GFR unchanged: blocked secretion or a fooled assay.

  1. Cr Creatinine rises Mild, soon after a culprit drug.
  2. Secretion blocked Filtration unchanged; tubular exit shut.
  3. Cys C Cystatin C unchanged True GFR preserved: not kidney injury.
  1. 1

    Stop 1 · Recognition

    Clinical features of pseudo-AKI

    An isolated, mild rise timed to a known culprit drug.

    +10–30% plateau baseline drug started
    1

    Timing

    Step rise within about a month of starting; then plateau.

    2

    Size

    Typically mild, 10–30%.

    3

    Bystanders

    No oliguria; urea unaffected; bland dipstick.

    Ask: drug chart timing, cooked meat, creatine supplements, muscle mass, vomiting or poor intake.
    Rapid reversal within a few days of stopping. eGFRcr far below eGFRcys points to a secretion blocker.

    Classic case Co-trimoxazole, creatinine up 20% in 3 days: expected pseudo-rise.

    Memory hook

    “Step, plateau, bland urine.”

    Exam trap

    Creatinine is reliable only in a steady state: exclude true AKI by urine output, volume and BP.

  2. 2

    Stop 2 · Mechanism

    Tubular creatinine secretion

    Subscribers only

Unlock the other 5 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Drugs that inhibit creatinine secretion
  2. Assay interference and non-drug causes
  3. GFR evaluation (KDIGO 2024)
  4. Management and red flags
See the plans →
49

Renal biopsy indications & complications

Open the full topic →
Fast Recap · six stops

Kidney biopsy at a glance

A biopsy must change management; its price is bleeding. Prepare well, then watch the haematocrit.

  1. Valid indication The result must change treatment.
  2. Bleeding prevention Control BP, hold drugs, check clotting.
  3. Haematoma Falling haematocrit: image, then embolise.
  1. 1

    Stop 1 · Indications

    Indications for kidney biopsy

    Unexplained disease, or a syndrome where histology decides therapy.

    AKI
    Unexplained, only after excluding pre-renal, post-renal and ATN.
    CKD
    Unexplained; not if kidneys <9 cm.
    Nephrotic (adult)
    Except suspected minimal change or diabetic nephropathy.
    Proteinuria
    Non-nephrotic >1 g/24h.
    Systemic / nephritic
    SLE, vasculitis; acute nephritic syndrome.
    Transplant
    Dysfunction after excluding obstruction and renal artery stenosis.
    Rarely
    Isolated microscopic haematuria: suspected glomerular, or with proteinuria.
    Memory hook

    “No change in treatment or prognosis, no needle.”

    Exam trap

    Hypertension + proteinuria: evaluate first; biopsy only if the picture stays unclear.

  2. 2

    Stop 2 · Safety

    Contraindications

    Subscribers only

Unlock the other 5 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Pre-biopsy preparation
  2. Uraemic platelet dysfunction
  3. Post-biopsy monitoring
  4. Management of post-biopsy haemorrhage
See the plans →
92

Lupus nephritis — pregnancy planning and proteinuria rise after MMF→azathioprine

Open the full topic →
Fast Recap · 7 stops

Lupus nephritis pregnancy at a glance

Quiet disease, pregnancy-safe drugs, then conceive. A proteinuria rise after the switch is a flare until proven otherwise.

  1. 6 months Quiescence first At least 6 months of inactive LN.
  2. MMF AZA HCQ + Safe-drug switch MMF off ≥6 weeks; add hydroxychloroquine.
  3. 0.4 1.6 ? g/day Proteinuria rises Pregnancy test, sediment, serology, then biopsy.
  1. 1

    Stop 1 · Assessment

    Pre-conception risk assessment

    At least 6 months of inactive LN before conception.

    ≥6 months LA uPCR <0.5 g/g
    1

    Complete response

    uPCR <0.5 g/g, stable function.

    2

    Sediment

    Bland, read myself.

    3

    Serology

    Quiet C3, C4, anti-dsDNA.

    Screen: antiphospholipid antibodies (lupus anticoagulant), anti-Ro/La, BP, platelets, creatinine.

    Poor outcome (CCN 2023)

    Creatinine >0.9 mg/dL, proteinuria >0.5 g/day, APS, hypertension, active disease.

    PROMISSE predictors

    Lupus anticoagulant (OR 8.3), antihypertensive use (OR 7.1), low platelets.

    Previous LN: more maternal complications and flares; fetal outcomes similar. Contraception continues until the switch is done and remission proven.

    Memory hook

    “At least six months quiet, at least six weeks off MMF.”

  2. 2

    Stop 2 · Medication

    Pre-conception drug plan

    Subscribers only

Unlock the other 6 stops

Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.

  1. Drug safety in pregnancy
  2. Differential diagnosis of rising proteinuria
  3. Flare versus haemodynamic proteinuria
  4. Management of a confirmed flare
  5. Flare in pregnancy and antenatal monitoring
See the plans →
Home All Topics Contact Us Terms of Service Privacy Policy Refund Policy Facebook YouTube Monawib

Tools: Nephrology tools · Radiology

Disclaimer: NephroApp is an independent educational platform and is not affiliated with, endorsed by, or sponsored by any licensing authority, examination provider, or textbook publisher. The MCQ Bank provides exam-style practice for educational purposes.

Nephroapp© 2026. All rights reserved.

Made with by Dr. Hossam Abohassan